Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

MS Patients' Self-Awareness of movement under the microscope

NCT ID NCT07175792

Knowledge-focused Sponsor: Hasselt University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study compares how accurately people with multiple sclerosis (MS) and healthy controls perceive changes in their own walking and sit-to-stand performance. Researchers will measure how well participants detect natural variations in their movement speed and smoothness. The goal is to uncover specific perception deficits in MS that could guide future personalized therapies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could identify specific perception deficits in MS and help design tailored interventions to improve motor performance awareness.
What could go wrong
This is an observational study with no treatment, so it cannot directly improve health. Results may not lead to clear clinical changes or apply to all MS patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

72 people

The number who actually took part.

Started

Dec 2024

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

44 PwMS and 44 healthy controls will be recruited from the Flemish MS rehabilitation centers in Melsbroek (NMSC) and Pelt (Noorderhart RMSC), and as well from the REVAL research center in UHasselt. No economical compensation will be provided. We will search age and sex-matching healthy controls, considering a 5-year range per subject. After giving informed consent, demographics of age and gender, height and weight, years of education, as well as MS-related information such as EDSS, type of MS, use of assistive device for walking in daily life, and year of diagnosis, will be collected and provided by the centers or via self-report. The participants will be instructed to keep their normal routine but to avoid extraneous physical activity at least 24 hours before the data collection session.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age between 18 and 70 years old * ability to walk for 6 minutes without rest and without the need of a walking aid * ability to repeatedly perform the sit to stand transitions on a standard chair (43cm seat height) without hand support For People with Multiple Sclerosis group * a diagnosis of MS (2017 revisions of the McDonalds criteria) * no disease relapses \>1 month preceding the start of the study Exclusion Criteria: * cognitive impairment hindering understanding of study instructions * ongoing or suspected pregnancy * musculoskeletal disorders in the lower limbs * cardiovascular red flags for exercise (screened with Physical Activity Readines Questionnaire) * other diagnosis for neurological or metabolic disease limiting the full execution of the tests

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

Contacts and locations

Locations

  • Nationaal MS-Centrum Melsbroek

    Steenokkerzeel, Belgium, 1820, Belgium

  • Noorderhart Revalidatie & MS

    Overpelt, Belgium, 3900, Belgium

  • REVAL

    Diepenbeek, Belgium, 3590, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.